Pharmspective Publishes White Paper: Health Care Reform and the Reshaping of the Pharmaceutical Selling Model
How the Value of Pharmaceuticals Will be Redefined in 2014
NEW YORK, March 8, 2012 /PRNewswire/ -- Pharmspective, LLC today released the white paper, Health Care Reform and the Reshaping of the Pharmaceutical Selling Model, forecasting how health care reform will redefine the marketing & sales landscape of the pharmaceutical industry and transform customer relationships.
The Pharmspective white paper will cover the impact of healthcare reform changes on physicians, hospitals, payers, and employers and offer a window into how these changes will influence the roles of pharmaceutical field sales representatives, account managers, reimbursement specialists, hospital representatives, and customer marketing groups. The paper will also include a discussion of:
- The influence of State Exchanges and Medicare ACOs, post-2014
- The impact of employer decisions on access and coverage
- The environment facing physicians as new payer entities and third-party administrators emerge
"This legislation will require pharmaceutical manufacturers to build the rationale for therapy adoption across a broader set of decision influencers. In all cases, selling will require greater knowledge of the customer's reimbursement structure, business model, and incentives," says Stephen Reid, Managing Partner & Co-Founder of Pharmspective, LLC.
To learn more about how companies can navigate through the 400-plus key provisions of the healthcare reform legislation, click here to read the full report: www.pharmspective.com/download.php
Pharmspective recently published another white paper, Decision Visualization: Making Pharma Market Research More Relevant in a New Era, reporting on the new evolving decision-making process of prescribers of specialty therapeutics, also available at: www.pharmspective.com/download.php
About Pharmspective: www.pharmspective.com New York City St. Louis, MO.Contact: Jennifer Strathmann,
314-814-2729 x1002 [email protected]
www.pharmspective.com
SOURCE Pharmspective, LLC
Share this article